Treatment of neovascular age-related macular degeneration: Current therapies
Albert J Augustin, Stefan Scholl, Janna KirchhofDepartment of Ophthalmology, Klinikum Karlsruhe, GermanyAbstract: Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe vision loss among people over the age of 40 in the...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-01-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/treatment-of-neovascular-age-related-macular-degeneration-current-ther-a2776 |